International Assets Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

International Assets Investment Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$712	Hold	22	–	–	﹤0.01%	2245
2026 Q1	$471	Buy	+22	New	+$495	﹤0.01%	2133
2024 Q4	–	Sell	-10,388	Closed	-$187	–	1643
2024 Q3	$187	Buy	10,388 +10,353	+29,580%	+$527K	﹤0.01%	1550
2024 Q2	$1.44K	Buy	+35	New	+$1.49K	﹤0.01%	2052
2023 Q2	–	Sell	-47	Closed	-$1.89K	–	794
2023 Q1	$1.89K	Buy	+47	New	+$2.02K	﹤0.01%	999
2021 Q2	–	Sell	-44	Closed	-$6K	–	1562
2021 Q1	$6K	Buy	44 +22	+100%	+$3K	﹤0.01%	1744
2020 Q4	$3K	Buy	+22	New	+$2.61K	﹤0.01%	1811

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

International Assets Investment Management's RARE Position: Q2 2026 in Review

International Assets Investment Management held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 22 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

International Assets Investment Management first reported a position in RARE in Q4 2020 and has held it in 7 quarters since. The position peaked at $6K in Q1 2021. 157 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

International Assets Investment Management held 22 shares of Ultragenyx Pharmaceutical worth $712 as of Q2 2026.
International Assets Investment Management left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
Ultragenyx Pharmaceutical made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2245 holding.
International Assets Investment Management first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 7 quarters since.
International Assets Investment Management's Ultragenyx Pharmaceutical position peaked at $6K in Q1 2021.
157 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.